Accord Hlthcare Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has one hundred and thirty-nine approved drugs.

There are nine tentative approvals on ACCORD HLTHCARE drugs.

Summary for Accord Hlthcare

US Patents:	0
Tradenames:	121
Ingredients:	118
NDAs:	139

Drugs and US Patents for Accord Hlthcare

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Accord Hlthcare	OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	209281-002	Feb 7, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Accord Hlthcare	TACROLIMUS	tacrolimus	OINTMENT;TOPICAL	211688-002	Jan 31, 2019	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Accord Hlthcare	TEMOZOLOMIDE	temozolomide	CAPSULE;ORAL	201528-002	Feb 27, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.